Hepatitis B Virus Infection and Vaccine
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Medical Microbiology".
Deadline for manuscript submissions: 15 December 2024 | Viewed by 60
Special Issue Editor
Interests: hepatitis B virus; vaccine
Special Issue Information
Dear Colleagues,
With 50 years since the expanded program on immunization (EPI), and the introduction of the hepatitis B vaccine in the EPI as early as 30 years ago in some countries, it seems fitting to look again at hepatitis B infection, vaccines, and vaccination endeavors in countries around the world. This Special Issue intends to add to the understanding of hepatitis B virus (HBV) and its impact on infection, the progression of disease, novel design of or re-focus on targets for vaccines and drug development, and understanding successes in the current immunization era. With regard to the viral genome, new understandings and revelations to changes in the gene/s and their effects on disease are necessary for detection and control. Viral genetic change influences knowledge on targets for drug and vaccine improvement. With the introduction of the HBV birth dose vaccine in many countries, challenges and successes require reporting so that others can read of goals met and lessons learnt. This Special Issue necessitates a way forward to advance knowledge on HBV and its impact.
Dr. Nishi Prabdial-Sing
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hepatitis B virus
- infection
- vaccine
